Back to Journals » Patient Preference and Adherence » Volume 14

Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Experiment and Best–Worst Scaling

Total article views   HTML views PDF downloads Totals
6,392 Dovepress* 5,439+ 864 6,303
PubMed Central* 953 468 1,421
Totals 6,392 1,332 7,724
*Since 5 November 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar